Avanos Medical Q3 Adj. EPS $0.30 Beats $0.28 Estimate, Sales $171.30M Beat $169.60M Estimate
Portfolio Pulse from Benzinga Newsdesk
Avanos Medical (NYSE:AVNS) reported Q3 adjusted earnings of $0.30 per share, beating the analyst consensus estimate of $0.28 by 7.14%. However, this is a 21.05% decrease from the same period last year. The company also reported quarterly sales of $171.30 million, beating the estimate of $169.60 million by 1.00%, but this is a 15.24% decrease from the same period last year.
November 01, 2023 | 11:16 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Avanos Medical's Q3 earnings and sales beat estimates but are down YoY. This mixed result could lead to uncertain market reactions.
Avanos Medical's Q3 earnings and sales beat estimates, which is positive. However, the YoY decrease in both earnings and sales could be a concern for investors, leading to potential uncertainty in the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100